• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Quick Take: Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers

byDonna LeetandAliya Ramjaun
September 3, 2019
in Cardiology, Chronic Disease, Oncology
Reading Time: 2 mins read
1
Share on FacebookShare on Twitter

RELATED REPORTS

Torsemide not associated with significant difference in all-cause mortality over 12 months compared to furosemide – The TRANSFORM-HF randomized clinical trial

Clinical decision-making strategy improves acute heart failure outcomes

Chlorthalidone is not superior to hydrochlorothiazide in preventing hypertension-related cardiovascular events

With the large and growing population of cancer survivors over the last several decades, there exists significant concern that these patients may be at an increased risk of cardiovascular disease. However, few studies have examined risks of multiple specific outcomes of cardiovascular disease in survivors of a wide range of cancers. In this population-based cohort study, 108,215 cancer survivors of the 20 most common cancers, alive 12 months after diagnosis, and 523,541 matched controls were studied to compare the risks of a range of long-term cardiovascular disease outcomes. Primary care, hospital, and cancer registry data were obtained through the UK Clinical Practice Research Datalink. At 10 years after cancer diagnosis, 15.2% of cancer survivors and 19.0% of controls were still under follow-up. At baseline, smoking, hypertension, previous history of cardiovascular disease, and chronic kidney disease were slightly more prevalent in cancer survivors than matched controls, whereas heavy drinking was slightly less prevalent in cancer survivors than matched controls at baseline. Researchers found that cancer survivors were at an increased risk of venous thromboembolism (in 18 of 20 cancers), heart failure or cardiomyopathy (10 of 20 cancers), arrhythmia (8 of 20 cancers), pericarditis (8 of 15 cancers), coronary artery disease (5 of 20 cancers), stroke (5 of 20 cancers), and valvular heart disease (3 of 18 cancers) (by adjusted HRs, p<0.01 for all). Survivors of hematological malignancies were at increased risk of all cardiovascular outcomes, whereas the risk pattern was more varied for survivors of other types of cancers. Furthermore, there was an increased risk of heart failure or cardiomyopathy and venous thromboembolism in younger patients and patients without previous cardiovascular disease in a variety of cancers; this risk was most pronounced in patients who had received chemotherapy. Overall, results from this study suggest that cancer survivors are at an increased risk of multiple cardiovascular disease as compared to the general population, underlining a need for more intensive cardiovascular disease screening, prevention, and management strategies in this patient population.

Click to read the study in Lancet

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cancer survivorsCardiomyopathycardiovascular diseasecoronary artery disease (CAD)heart failurevenous thromboembolism
Previous Post

2 Minute Medicine Rewind September 2, 2019

Next Post

The PIONEER 6 trial: semaglutide in type 2 diabetic patients does not increase cardiovascular risk

RelatedReports

Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors
Cardiology

Torsemide not associated with significant difference in all-cause mortality over 12 months compared to furosemide – The TRANSFORM-HF randomized clinical trial

January 24, 2023
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

Clinical decision-making strategy improves acute heart failure outcomes

January 12, 2023
Preterm birth associated with cardiovascular risk factors in adolescence
Cardiology

Chlorthalidone is not superior to hydrochlorothiazide in preventing hypertension-related cardiovascular events

January 4, 2023
No association found between length of storage for transfused red blood cells and patient mortality
Cardiology

Ferric derisomaltose may reduce heart failure-related hospitalizations

December 27, 2022
Next Post
Type 2 diabetes associated with reduction in disability-free life years

The PIONEER 6 trial: semaglutide in type 2 diabetic patients does not increase cardiovascular risk

#VisualAbstract: Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections

#VisualAbstract: Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections

Evidence-based interventions for pediatric asthma successfully adapted for community health centers

Quick Take: Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL)

Please login to join discussion

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Rocatinlimab may be effective in the treatment of moderate-to-severe atopic dermatitis
  • Gender-affirming hormones improve psychosocial functioning in transgender youth
  • Left atrial reservoir strain improves ischemic stroke risk prediction in low-risk patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options